Literature DB >> 29602068

Ectromelia virus lacking the E3L ortholog is replication-defective and nonpathogenic but does induce protective immunity in a mouse strain susceptible to lethal mousepox.

Tiffany R Frey1, Katherine S Forsyth2, Maura M Sheehan1, Brian C De Haven3, Julia G Pevarnik1, Erin S Hand1, Marie C Pizzorno4, Laurence C Eisenlohr5, Adam R Hersperger6.   

Abstract

All known orthopoxviruses, including ectromelia virus (ECTV), contain a gene in the E3L family. The protein product of this gene, E3, is a double-stranded RNA-binding protein. It can impact host range and is used by orthopoxviruses to combat cellular defense pathways, such as PKR and RNase L. In this work, we constructed an ECTV mutant with a targeted disruption of the E3L open reading frame (ECTVΔE3L). Infection with this virus resulted in an abortive replication cycle in all cell lines tested. We detected limited transcription of late genes but no significant translation of these mRNAs. Notably, the replication defects of ECTVΔE3L were rescued in human and mouse cells lacking PKR. ECTVΔE3L was nonpathogenic in BALB/c mice, a strain susceptible to lethal mousepox disease. However, infection with ECTVΔE3L induced protective immunity upon subsequent challenge with wild-type virus. In summary, E3L is an essential gene for ECTV.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Double-stranded RNA; E3L gene; Ectromelia virus; Host range gene; Innate immune evasion; Mousepox virus; PKR; dsRNA

Mesh:

Substances:

Year:  2018        PMID: 29602068      PMCID: PMC5911240          DOI: 10.1016/j.virol.2018.03.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  74 in total

Review 1.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

2.  Studies in infectious ectromelia in mice; natural transmission; the portal of entry of the virus.

Authors:  F FENNER
Journal:  Aust J Exp Biol Med Sci       Date:  1947-09

3.  Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA.

Authors:  H W Chang; B L Jacobs
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

4.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

Authors:  Ying Xiang; Richard C Condit; Sangeetha Vijaysri; Bertram Jacobs; Bryan R G Williams; Robert H Silverman
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  The genomic sequence of ectromelia virus, the causative agent of mousepox.

Authors:  Nanhai Chen; Maria I Danila; Zehua Feng; R Mark L Buller; Chunlin Wang; Xiaosi Han; Elliot J Lefkowitz; Chris Upton
Journal:  Virology       Date:  2003-12-05       Impact factor: 3.616

8.  Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene.

Authors:  E Beattie; K L Denzler; J Tartaglia; M E Perkus; E Paoletti; B L Jacobs
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

9.  Classic paper: Fenner on the exanthemata.

Authors:  Frank Fenner
Journal:  Rev Med Virol       Date:  2006 Nov-Dec       Impact factor: 6.989

10.  Adaptive gene amplification as an intermediate step in the expansion of virus host range.

Authors:  Greg Brennan; Jacob O Kitzman; Stefan Rothenburg; Jay Shendure; Adam P Geballe
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

View more
  1 in total

1.  Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading.

Authors:  Katherine S Forsyth; Nathan H Roy; Elise Peauroi; Brian C DeHaven; Erik D Wold; Adam R Hersperger; Janis K Burkhardt; Laurence C Eisenlohr
Journal:  PLoS Pathog       Date:  2020-08-03       Impact factor: 6.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.